Argos Therapeutics to Participate in Upcoming Investor Conferences
Nov 11, 2016 13:00 pm UTC| Business
DURHAM, N.C., Nov. 11, 2016 -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis®...
Nov 11, 2016 13:00 pm UTC| Business
NEW YORK, Nov. 11, 2016 -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral...
El Pollo Loco to Present at the Morgan Stanley Global Consumer & Retail Conference 2016
Nov 11, 2016 13:00 pm UTC| Business
COSTA MESA, Calif., Nov. 11, 2016 -- El Pollo Loco (Nasdaq:LOCO), the nation's leading fire-grilled chicken restaurant chain, announced today that Steve Sather, chief executive officer, Larry Roberts, chief financial...
Assembly Biosciences to Present Data on ABI-H0731 at AASLD 2016 Liver Meeting
Nov 11, 2016 13:00 pm UTC| Business
INDIANAPOLIS, Nov. 11, 2016 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel...
Nov 11, 2016 13:00 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, Ca., Nov. 11, 2016 -- Immune Design, a clinical-stage immunotherapy company focused on oncology, today announced new preclinical data demonstrating the ability of its ZVex discovery...
Nov 11, 2016 13:00 pm UTC| Business
Trial to Assess Potential Effects of MYK-461 Treatment on Arterial Pulse Wave Morphology as Measured by Investigational Optical Biosensor Wristband SOUTH SAN FRANCISCO, Calif., Nov. 11, 2016 -- MyoKardia, Inc....
CSW Industrials Reports Fiscal Second Quarter 2017 Results
Nov 11, 2016 13:00 pm UTC| Business
Highlights Second quarter 2017 net revenue of $80.1 million, compared to $83.7 million in the prior year period.Second quarter 2017 GAAP operating income of $7.0 million; Non-GAAP operating income of $11.5 million.Second...